ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
Brain Aging Project--Kansas University

This study is currently recruiting participants.
Verified by National Institute on Aging (NIA), September 2007

Sponsors and Collaborators: National Institute on Aging (NIA)
University of Kansas
Information provided by: National Institute on Aging (NIA)
ClinicalTrials.gov Identifier: NCT00267124
  Purpose

The purpose of this study is to determine the effects of exercise and cardiorespiratory fitness on age-related brain changes.


Condition
Alzheimer's Disease

Genetics Home Reference related topics:   Alzheimer disease  

MedlinePlus related topics:   Alzheimer's Caregivers   Alzheimer's Disease  

U.S. FDA Resources

Study Type:   Observational
Study Design:   Longitudinal, Defined Population, Prospective Study
Official Title:   KU Brain Aging Project

Further study details as provided by National Institute on Aging (NIA):

Estimated Enrollment:   120
Study Start Date:   November 2004

Detailed Description:

The mission of the KU Brain Aging Project is to promote healthy brain aging. How the brain changes with age is not well-characterized and even less is known about the factors influencing the rate of brain aging. Thus, we are using MRI scans to examine the structure of the brain in relation to important lifestyle factors. This will allow us to better understand the processes influencing the brain as it ages. In turn, this will help identify specific ways to promote healthy brain aging and, perhaps, prevent the onset of Alzheimer's disease.

Participants complete 4 visits over several months. The first visit entails a clinical evaluation and memory testing involving the use of paper and pencil testing. The second visit is an MRI brain scan which lasts approximately one hour. The third visit involves drawing blood for laboratory testing and blood banking for future lab studies, lasting roughly 4 hours. The glucose tolerance test is administered. The fourth and final visit is an assessment of the participant's metabolism and exercise testing. This visit lasts approximately two hours.

  Eligibility
Ages Eligible for Study:   65 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes

Criteria

Inclusion Criteria:

  • Age 65 years or older
  • Healthy male or female
  • Normal control volunteers and early Alzheimer's disease patients
  • Clinical Dementia Rating of 0, 0.5, or 1.0
  • On stable doses of medications

Exclusion Criteria:

  • Unstable angina
  • Schizophrenia
  • Clinical signs of depression; major depression; mental health disorder; nervous system disorder
  • Significant visual/auditory impairment
  • Significant system illness; cancer
  • Pacemaker/metal
  • Thyroid problems
  • Kidney dialysis
  • Organ transplant
  • Alcoholism
  • Heart surgery
  • Insulin
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00267124

Contacts
Contact: M. Pat Laubinger, MPA, BSN     913-588-0685     plaubinger@kumc.edu    

Locations
United States, Kansas
University of Kansas Medical Center     Recruiting
      Kansas City, Kansas, United States, 66160
      Contact: Jeffrey Burns, MD     913-588-0555     jburns2@kumc.edu    
      Contact: M. Pat Laubinger, MPA, BSN     913-588-0685     plaubinger@kumc.edu    

Sponsors and Collaborators
National Institute on Aging (NIA)
University of Kansas

Investigators
Principal Investigator:     Jeffrey Burns, MD     University of Kansas Medical Center, Landon Center on Aging    
  More Information

KU Brain Imaging Project  This link exits the ClinicalTrials.gov site
 

Study ID Numbers:   IA0089, 1R03AG026374-01
First Received:   December 16, 2005
Last Updated:   September 19, 2007
ClinicalTrials.gov Identifier:   NCT00267124
Health Authority:   United States: Federal Government

Keywords provided by National Institute on Aging (NIA):
cognitive decline  
dementia  
neuroimaging  

Study placed in the following topic categories:
Delirium, Dementia, Amnestic, Cognitive Disorders
Alzheimer Disease
Central Nervous System Diseases
Neurodegenerative Diseases
Brain Diseases
Dementia
Cognition Disorders
Delirium

Additional relevant MeSH terms:
Mental Disorders
Nervous System Diseases
Tauopathies

ClinicalTrials.gov processed this record on May 11, 2008